148 related articles for article (PubMed ID: 31934230)
21. Usefulness of endometrial aspiration cytology for the preoperative diagnosis of ovarian carcinoma.
Jobo T; Arai M; Iwaya H; Kato Y; Ohno E; Kuramoto H
Acta Cytol; 1999; 43(2):104-9. PubMed ID: 10097693
[TBL] [Abstract][Full Text] [Related]
22. Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium.
Iwamoto M; Nakatani Y; Fugo K; Kishimoto T; Kiyokawa T
Hum Pathol; 2015 Jul; 46(7):957-62. PubMed ID: 25971546
[TBL] [Abstract][Full Text] [Related]
23. Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation: a case study.
Ohishi Y; Kaku T; Kaneki E; Wake N; Tsuneyoshi M
Gynecol Oncol; 2007 May; 105(2):548-52. PubMed ID: 17341430
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
[TBL] [Abstract][Full Text] [Related]
25. [A case report for primary yolk sac tumor of endometrium].
Hu Y; Zeng F; Xue M; Xiao S
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Dec; 41(12):1362-1365. PubMed ID: 28070053
[TBL] [Abstract][Full Text] [Related]
26. Clinical Significance of Tissue Factor Pathway Inhibitor 2, a Serum Biomarker Candidate for Ovarian Clear Cell Carcinoma.
Arakawa N; Kobayashi H; Yonemoto N; Masuishi Y; Ino Y; Shigetomi H; Furukawa N; Ohtake N; Miyagi Y; Hirahara F; Hirano H; Miyagi E
PLoS One; 2016; 11(10):e0165609. PubMed ID: 27798689
[TBL] [Abstract][Full Text] [Related]
27. Ovarian malignant mixed germ cell tumor with clear cell carcinoma in a postmenopausal woman.
Yu XJ; Zhang L; Liu ZP; Shi YQ; Liu YX
Int J Clin Exp Pathol; 2014; 7(12):8996-9001. PubMed ID: 25674278
[TBL] [Abstract][Full Text] [Related]
28. Gastric adenocarcinoma with a yolk sac component: a case report and review of the literature.
Wang L; Tabbarah HJ; Gulati P; Rice S; French SW
J Clin Gastroenterol; 2000 Jul; 31(1):85-8. PubMed ID: 10914786
[TBL] [Abstract][Full Text] [Related]
29. Alpha-fetoprotein-producing serous carcinoma of the uterus metastasizing to the ovaries, mimicking primary ovarian yolk sac tumor: a case report and review of the literature.
Tran TA; Ortiz HB; Holloway RW; Bigsby GE; Finkler NJ
Int J Gynecol Pathol; 2007 Jan; 26(1):66-70. PubMed ID: 17197899
[TBL] [Abstract][Full Text] [Related]
30. A case of ovarian endometrioid adenocarcinoma with a yolk sac tumor component.
Abe A; Furumoto H; Yoshida K; Nishimura M; Irahara M; Kudo E; Sano T
Int J Gynecol Cancer; 2008; 18(1):168-72. PubMed ID: 17466041
[TBL] [Abstract][Full Text] [Related]
31. Ovarian yolk sac tumors in older women arising from epithelial ovarian tumors or with no detectable epithelial component.
Roth LM; Talerman A; Levy T; Sukmanov O; Czernobilsky B
Int J Gynecol Pathol; 2011 Sep; 30(5):442-51. PubMed ID: 21804392
[TBL] [Abstract][Full Text] [Related]
32. Napsin A and WT 1 are useful immunohistochemical markers for differentiating clear cell carcinoma ovary from high-grade serous carcinoma.
Rekhi B; Deodhar KK; Menon S; Maheshwari A; Bajpai J; Ghosh J; Shylasree ST; Gupta S
APMIS; 2018 Jan; 126(1):45-55. PubMed ID: 29266433
[TBL] [Abstract][Full Text] [Related]
33. Germ cell tumors. Case 3. Primary yolk sac tumor of the liver.
Toumi N; Chaumette-Plankaert MT; Cherqui D; de Revel T; Duvillard P; Theodore C
J Clin Oncol; 2004 May; 22(9):1756-8. PubMed ID: 15118001
[No Abstract] [Full Text] [Related]
34. Primary yolk sac tumour of the liver in adulthood.
Wong NA; D'Costa H; Barry RE; Alderson D; Moorghen M
J Clin Pathol; 1998 Dec; 51(12):939-40. PubMed ID: 10070339
[TBL] [Abstract][Full Text] [Related]
35. The yolk sac tumor: reflections on a remarkable neoplasm and two of the many intrigued by it-Gunnar Teilum and Aleksander Talerman-and the bond it formed between them.
Young RH
Int J Surg Pathol; 2014 Dec; 22(8):677-87. PubMed ID: 25395492
[TBL] [Abstract][Full Text] [Related]
36. Ovarian yolk sac tumor with endometrioid carcinoma arising from endometriosis in a postmenopausal woman, with special reference to expression of alpha-fetoprotein, sex steroid receptors, and p53.
Horiuchi A; Osada R; Nakayama K; Toki T; Nikaido T; Fujii S
Gynecol Oncol; 1998 Aug; 70(2):295-9. PubMed ID: 9740709
[TBL] [Abstract][Full Text] [Related]
37. Ovarian endometrioid carcinoma with yolk sac component in a young patient: a diagnostic and therapeutic dilemma.
Kane SV; Wuntkal R; Ramadwar M; Tongaonkar HB
Aust N Z J Obstet Gynaecol; 2004 Aug; 44(4):364-6. PubMed ID: 15282017
[No Abstract] [Full Text] [Related]
38. Clear cell carcinoma simulating the "endometrioid-like variant" of yolk sac tumor.
Ballotta MR; Bianchini E; Borghi L; Fortini RM
Pathologica; 1995 Feb; 87(1):87-90. PubMed ID: 7567174
[TBL] [Abstract][Full Text] [Related]
39. Clear cell tumors of the female genital tract.
Matias-Guiu X; Lerma E; Prat J
Semin Diagn Pathol; 1997 Nov; 14(4):233-9. PubMed ID: 9383823
[TBL] [Abstract][Full Text] [Related]
40. Cytology of brain metastasis of yolk sac tumor.
Geramizadeh B; Daneshbood Y; Karimi M
Acta Cytol; 2005; 49(1):110-1. PubMed ID: 15717767
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
